May 15, 2024 — etherFAX has announced the expansion of its partnership with Hyland, a global provider of intelligent content solutions, with its new integration with Hyland’s OnBase platform. Through the integration, etherFAX and Hyland are enabling healthcare organizations to securely exchange protected health information (PHI) via the cloud.

May 14, 2024 — Indica Labs, the leading provider of digital pathology solutions, announced today that it received FDA clearance for 

May 14, 2024 — University Hospitals (UH) and Siemens Healthineers announce a 10-year strategic alliance that builds on their 40-year history of clinical and research collaboration. This ambitious next phase will support UH’s focus on improving oncology, cardiovascular, and neurovascular care for patients in Ohio.

May 14, 2024 — Elekta announced the launch of its latest linear accelerator (linac), Evo*, a CT-Linac with new high-definition AI enhanced imaging, capable of delivering offline and online adaptive radiation therapy as well as improved standard image-guided radiation therapy treatments.

May 13, 2024 — In the wake of the cybersecurity breach targeting the prominent healthcare system Ascension, a new study has unveiled the industries most susceptible to cyberattacks. Alarmingly, the healthcare sector has been revealed as the most vulnerable, underscoring the urgent need for heightened security within healthcare companies.

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next Gen Basketball Players Union (NBGPU) in collaboration with GE HealthCare and MedStar Health announced the completion of the data collection phase of a longitudinal pilot study of NBA G League players.

Radiology, once confined to dark rooms with X-ray films hanging from light boxes, has transformed at a rapid-fire pace over the past few decades. Today, it stands at the forefront of medical innovation, driven by technological advancements and in keeping pace with ever-evolving healthcare needs. 

May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 

May 10, 2024 — Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer, today announced it will be acquired by Novartis for $1 billion upfront and up to $750 million in potential milestone payments.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now